In the DFCI cohort, colorectal cancers with wild type BRAF had TMB above 200 in 35% of cases when PIK3CA was mutant and in 18.5% of cases when PIK3CA was also wild type (Table 4). This evidence concerns the gene PIK3CA and colorectal cancer.